Technical Analysis for VIR - Vir Biotechnology, Inc.

Grade Last Price % Change Price Change
C 62.63 -2.31% -1.48
VIR closed down 2.31 percent on Friday, February 26, 2021, on 54 percent of normal volume.

Trend Table & Recent EOD Signals

ADX Long Term Intermediate Term Short Term
Strong Up Up Down
Historical VIR trend table...

Date Alert Name Type % Chg
1,2,3 Pullback Bullish Bullish Swing Setup 0.00%
Non-ADX 1,2,3,4 Bullish Bullish Swing Setup 0.00%
Earnings Movers Other 0.00%
Multiple of Ten Bullish Other 0.00%
Wide Bands Range Expansion 0.00%
Lower Bollinger Band Touch Weakness 0.00%
20 DMA Resistance Bearish -2.31%
1,2,3 Pullback Bullish Bullish Swing Setup -2.31%
Non-ADX 1,2,3,4 Bullish Bullish Swing Setup -2.31%
Earnings Movers Other -2.31%
Older End-of-Day Signals for VIR ...

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Alert Time
60 Minute Opening Range Breakout about 16 hours ago
Down 5% about 19 hours ago
Down 3% about 19 hours ago
Down 2 % about 19 hours ago
Down 1% about 19 hours ago
View Earlier Intraday Alerts

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Vir Biotechnology, Inc. Description

Vir Biotechnology, Inc., a clinical-stage immunology company, develops therapeutic products for the treatment and prevention of serious infectious diseases. It develops VIR-2218 and VIR-3434 for the treatment of hepatitis B virus; VIR-2482 for the prevention of influenza A virus; VIR-1111 for the prevention of human immunodeficiency virus, and VIR-2020 for the prevention of tuberculosis. The company has grant agreement with Bill & Melinda Gates Foundation and National Institutes of Health; option and license agreement with Brii Biosciences Limited and Brii Biosciences Offshore Limited; collaboration and license agreement Alnylam Pharmaceuticals, Inc.; collaboration, license and option agreement Visterra, Inc.; and license agreement with The Rockefeller University and MedImmune, Inc. It operates in the United States, Oregon, Massachusetts, and Switzerland. The company was founded in 2016 and is headquartered in San Francisco, California.


Classification

Sector: Healthcare
Industry: Biotechnology
Keywords: Biotechnology Immunology Infectious Diseases Influenza Therapeutic Product Coronavirus Therapeutic Products Hepatitis B Immunodeficiency Hepatitis B Virus Pharmaceutical Companies Dimm Alnylam Pharmaceuticals Treatment Of Hepatitis Tuberculosis Therapeutic Medimmune Treatment Of Hepatitis B Rockefeller University Serious Infectious Diseases

Is VIR a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 138.5
52 Week Low 25.31
Average Volume 1,749,210
200-Day Moving Average 40.89
50-Day Moving Average 49.46
20-Day Moving Average 68.73
10-Day Moving Average 68.82
Average True Range 9.35
ADX 46.84
+DI 34.07
-DI 16.94
Chandelier Exit (Long, 3 ATRs ) 110.45
Chandelier Exit (Short, 3 ATRs ) 77.91
Upper Bollinger Band 79.36
Lower Bollinger Band 58.09
Percent B (%b) 0.21
BandWidth 30.95
MACD Line 4.20
MACD Signal Line 6.60
MACD Histogram -2.3996
Fundamentals Value
Market Cap 7.98 Billion
Num Shares 127 Million
EPS -5.76
Price-to-Earnings (P/E) Ratio -10.87
Price-to-Sales 52.45
Price-to-Book 4.90
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 73.27
Resistance 3 (R3) 72.49 68.16 71.49
Resistance 2 (R2) 68.16 65.45 68.55 70.90
Resistance 1 (R1) 65.40 63.78 66.78 66.18 70.31
Pivot Point 61.07 61.07 61.77 61.46 61.07
Support 1 (S1) 58.31 58.36 59.69 59.09 54.95
Support 2 (S2) 53.98 56.69 54.37 54.36
Support 3 (S3) 51.22 53.98 53.77
Support 4 (S4) 52.00